Items where authors include "Black, CJ"

Article

Black, CJ, Ng, C-E, Goodoory, VC orcid.org/0000-0001-9483-5604 et al. (1 more author) (2024) Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden. Clinical Gastroenterology and Hepatology, 22 (2). pp. 386-396. ISSN 1542-3565

Wise, J, Ingrosso, MR, Ianiro, G et al. (3 more authors) (2023) Response and Adverse Event Rates with Placebo in Gastroparesis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 21 (6). pp. 1447-1461. ISSN 1542-3565

Black, CJ, McKenzie, YA, Scofield-Marlowe, M et al. (4 more authors) (2023) Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership. The Lancet Gastroenterology and Hepatology, 8 (6). pp. 499-501. ISSN 2468-1253

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2023) Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (10). pp. 1083-1092. ISSN 0269-2813

Ingrosso, MR, Camilleri, M, Tack, J et al. (3 more authors) (2023) Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis. Gastroenterology, 164 (4). pp. 642-654. ISSN 0016-5085

Din, S, Selinger, CP, Black, CJ et al. (1 more author) (2023) Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 57 (6). pp. 666-675. ISSN 0269-2813

Fairbrass, KM, Guthrie, EA orcid.org/0000-0002-5834-6616, Black, CJ et al. (3 more authors) (2023) Characteristics and Impact of Anxiety and Depression Trajectories in Inflammatory Bowel Disease. American Journal of Gastroenterology, 118 (2). pp. 304-316. ISSN 0002-9270

Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis. Gut, 72 (2). pp. 264-274. ISSN 0017-5749

Visaggi, P, Ghisa, M, Barberio, B et al. (7 more authors) (2023) Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials. Digestive and Liver Disease, 55 (2). pp. 208-222. ISSN 1590-8658

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2023) Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome. Neurogastroenterology & Motility, 35 (2). e14483. ISSN 1350-1925

Goodoory, VC orcid.org/0000-0001-9483-5604, Guthrie, EA orcid.org/0000-0002-5834-6616, Ng, CE et al. (2 more authors) (2023) Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (3). pp. 323-334. ISSN 0269-2813

Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn’s Disease: Meta-analysis. Inflammatory Bowel Diseases. izac263. ISSN 1078-0998

Black, CJ, Houghton, LA orcid.org/0000-0002-5351-0229 and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities. Neurogastroenterology & Motility, 34 (11). e14391. ISSN 1350-1925

Burr, NE, Gracie, DJ, Black, CJ et al. (1 more author) (2022) Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. Gut, 71 (10). pp. 1976-1987. ISSN 0017-5749

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living. Alimentary Pharmacology and Therapeutics (AP&T), 56 (5). pp. 844-856. ISSN 0269-2813

Ingrosso, MR, Ianiro, G, Nee, J et al. (4 more authors) (2022) Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 56 (6). pp. 932-941. ISSN 0269-2813

Black, CJ, Paine, PA, Agrawal, A et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Alimentary Pharmacology & Therapeutics, 56 (1). pp. 110-120. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Craig, OF, Gracie, DJ et al. (2 more authors) (2022) Prognosis of patients with Rome IV‐defined versus physician‐diagnosed irritable bowel syndrome: Longitudinal follow‐up study. Neurogastroenterology & Motility, 34 (6). e14282. ISSN 1350-1925

Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis. Neurogastroenterology & Motility, 34 (6). e14279. ISSN 1350-1925

Black, CJ, Staudacher, HM and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 71 (6). pp. 1117-1126. ISSN 0017-5749

Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome. Gastroenterology, 162 (6). 1752-1754.e1. ISSN 0016-5085

Goodoory, VC orcid.org/0000-0001-9483-5604, Houghton, LA orcid.org/0000-0002-5351-0229, Black, CJ et al. (1 more author) (2022) Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterology & Motility, 34 (5). e14268. ISSN 1350-1925

Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis. Clinical Gastroenterology and Hepatology, 20 (5). E923-E944. ISSN 1542-3565

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 55 (10). pp. 1311-1319. ISSN 0269-2813

Barberio, B, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2022) Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-up Study. Clinical Gastroenterology and Hepatology, 20 (2). E89-E101. ISSN 1542-3565

Barberio, B, Segal, JP, Quraishi, MN et al. (3 more authors) (2021) Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. Journal of Crohn's and Colitis, 15 (7). pp. 1184-1196. ISSN 1873-9946

Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2021) Best management of irritable bowel syndrome. Frontline Gastroenterology, 12. pp. 303-315. ISSN 2041-4137

Vasant, DH, Paine, PA, Black, CJ et al. (10 more authors) (2021) British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 70 (7). pp. 1214-1240. ISSN 0017-5749

Nelson, AD, Black, CJ, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2021) Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating—a step in the right direction for targeted treatment? Authors' reply. Alimentary Pharmacology & Therapeutics, 54 (2). pp. 198-199. ISSN 0269-2813

Nelson, AD, Black, CJ, Houghton, LA et al. (3 more authors) (2021) Systematic review and network meta‐analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics, 54 (2). pp. 98-108. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Houghton, LA orcid.org/0000-0002-5351-0229, Yiannakou, Y et al. (2 more authors) (2021) Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study. Clinical Gastroenterology and Hepatology. ISSN 1542-3565

Barberio, B, Zamani, M, Black, CJ et al. (2 more authors) (2021) Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 6 (5). pp. 359-370. ISSN 2468-1253

Black, CJ, Yiannakou, Y, Guthrie, E orcid.org/0000-0002-5834-6616 et al. (3 more authors) (2021) Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value. Alimentary Pharmacology and Therapeutics, 53 (10). pp. 1126-1137. ISSN 0269-2813

Goodoory, VC, Mikocka-Walus, A, Yiannakou, Y et al. (3 more authors) (2021) Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. American Journal of Gastroenterology. ISSN 0002-9270

Mundre, P, Black, CJ, Mohammed, N et al. (1 more author) (2021) Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 6 (1). pp. 30-38. ISSN 2468-1253

Ford, AC orcid.org/0000-0001-6371-4359, Moayyedi, P, Black, CJ et al. (6 more authors) (2020) Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Alimentary Pharmacology & Therapeutics, 53 (1). pp. 8-21. ISSN 0269-2813

Barberio, B, Black, CJ, Savarino, EV et al. (1 more author) (2020) Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Journal of Crohn's and Colitis. ISSN 1873-9946

Black, CJ, Yiannakou, Y, Guthrie, EA et al. (3 more authors) (2020) A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. American Journal of Gastroenterology. ISSN 0002-9270

Black, CJ, Drossman, DA, Talley, NJ et al. (2 more authors) (2020) Functional gastrointestinal disorders: advances in understanding and management. The Lancet. ISSN 0140-6736

Barberio, B, Houghton, LA, Yiannakou, Y et al. (3 more authors) (2020) Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome. American Journal of Gastroenterology. ISSN 0002-9270

Black, CJ, Craig, O, Gracie, DJ et al. (1 more author) (2020) Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut. ISSN 0017-5749

Barberio, B, Mahadeva, S, Black, CJ et al. (2 more authors) (2020) Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Alimentary Pharmacology & Therapeutics, 52 (5). pp. 762-773. ISSN 0269-2813

Black, CJ, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (4 more authors) (2020) Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility, 32 (8). e13872. ISSN 1350-1925

Black, CJ, Thakur, ER, Houghton, LA et al. (3 more authors) (2020) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut, 69 (8). pp. 1441-1451. ISSN 0017-5749

Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews Gastroenterology & Hepatology, 17. pp. 473-486. ISSN 1759-5045

Oka, P, Parr, H, Barberio, B et al. (3 more authors) (2020) Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. ISSN 2468-1253

Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982 and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation. Clinical Gastroenterology and Hepatology, 18 (5). 1238-1239.E1. ISSN 1542-3565

Black, CJ, Houghton, LA and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea. American Journal of Gastroenterology, 115 (3). pp. 483-484. ISSN 0002-9270

Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Rational investigations in irritable bowel syndrome. Frontline Gastroenterology, 11 (2). pp. 140-147. ISSN 2041-4137

Black, CJ, Yuan, Y, Selinger, CP et al. (4 more authors) (2020) Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology and Hepatology, 5 (2). pp. 117-131. ISSN 2468-1253

Black, CJ, Yiannakou, Y, Houghton, LA et al. (1 more author) (2020) Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clinical Gastroenterology and Hepatology, 18 (2). pp. 392-398. ISSN 1542-3565

Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982, Camilleri, M et al. (5 more authors) (2020) Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut, 69 (1). pp. 74-82. ISSN 0017-5749

Eusebi, LH, Black, CJ, Howden, CW et al. (1 more author) (2019) Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis. BMJ, 367 (8226). l6483. ISSN 1756-1833

Luthra, P, Camilleri, M, Burr, NE orcid.org/0000-0003-1988-2982 et al. (3 more authors) (2019) Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. The lancet. Gastroenterology & Hepatology, 4 (11). pp. 831-844. ISSN 2468-1253

Black, CJ, Ford, AC orcid.org/0000-0001-6371-4359 and Houghton, LA (2019) Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Alimentary Pharmacology & Therapeutics, 50 (7). pp. 825-826. ISSN 0269-2813

Lim, SJ, Gracie, DJ, Kane, JS et al. (5 more authors) (2019) Prevalence of, and predictors of, bile acid diarrhea in outpatients with chronic diarrhea: A follow-up study. Neurogastroenterology and Motility, 31 (9). e13666. ISSN 1350-1925

Ianiro, G, Eusebi, LH, Black, CJ et al. (3 more authors) (2019) Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 50 (3). pp. 240-248. ISSN 0269-2813

Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982, Quigley, EMM et al. (3 more authors) (2018) Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. Gastroenterology, 155 (6). pp. 1753-1763. ISSN 0016-5085

Black, CJ, Houghton, LA and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Insights into the evaluation and management of dyspepsia: recent developments and new guidelines. Therapeutic Advances in Gastroenterology, 11. ISSN 1756-283X

Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Medical Journal of Australia, 209 (2). pp. 86-91. ISSN 1326-5377

Proceedings Paper

Black, CJ, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2021) Identification of novel subgroups in irritable bowel syndrome using latent class analysis: beyond stool form. In: Gut. Abstracts of the BSG Campus, 21-29 Jan 2021. BMJ , A208-A210.